These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22732150)

  • 61. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice.
    Fair PA; Driscoll E; Mollenhauer MA; Bradshaw SG; Yun SH; Kannan K; Bossart GD; Keil DE; Peden-Adams MM
    J Immunotoxicol; 2011; 8(1):17-29. PubMed ID: 21261439
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Absorption, distribution, and milk secretion of the perfluoroalkyl acids PFBS, PFHxS, PFOS, and PFOA by dairy cows fed naturally contaminated feed.
    Kowalczyk J; Ehlers S; Oberhausen A; Tischer M; Fürst P; Schafft H; Lahrssen-Wiederholt M
    J Agric Food Chem; 2013 Mar; 61(12):2903-12. PubMed ID: 23441933
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exposure to perfluorinated compounds and human semen quality in Arctic and European populations.
    Toft G; Jönsson BA; Lindh CH; Giwercman A; Spano M; Heederik D; Lenters V; Vermeulen R; Rylander L; Pedersen HS; Ludwicki JK; Zviezdai V; Bonde JP
    Hum Reprod; 2012 Aug; 27(8):2532-40. PubMed ID: 22647447
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Issues raised by the reference doses for perfluorooctane sulfonate and perfluorooctanoic acid.
    Dong Z; Bahar MM; Jit J; Kennedy B; Priestly B; Ng J; Lamb D; Liu Y; Duan L; Naidu R
    Environ Int; 2017 Aug; 105():86-94. PubMed ID: 28521193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
    Yang Q; Xie Y; Eriksson AM; Nelson BD; DePierre JW
    Biochem Pharmacol; 2001 Oct; 62(8):1133-40. PubMed ID: 11597582
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sub-acute, moderate-dose, but not short-term, low-dose dietary pre-exposure of mice to perfluorooctanoate aggravates concanavalin A-induced hepatitis.
    Qazi MR; Hassan M; Nelson BD; Depierre JW; Abedi-Valugerdi M
    Toxicol Lett; 2013 May; 219(1):1-7. PubMed ID: 23458897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC
    Wimsatt J; Villers M; Thomas L; Kamarec S; Montgomery C; Yeung LW; Hu Y; Innes K
    BMC Cancer; 2016 Dec; 16(1):942. PubMed ID: 27927180
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model.
    Shane HL; Baur R; Lukomska E; Weatherly L; Anderson SE
    Food Chem Toxicol; 2020 Feb; 136():111114. PubMed ID: 31904477
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adult dose-dependent behavioral and cognitive disturbances after a single neonatal PFHxS dose.
    Viberg H; Lee I; Eriksson P
    Toxicology; 2013 Feb; 304():185-91. PubMed ID: 23287389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tissue toxicokinetics of perfluoro compounds with single and chronic low doses in male rats.
    Iwabuchi K; Senzaki N; Mazawa D; Sato I; Hara M; Ueda F; Liu W; Tsuda S
    J Toxicol Sci; 2017; 42(3):301-317. PubMed ID: 28496036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increase in mouse liver weight following feeding of ammonium perfluorooctanoate and related fluorochemicals.
    Kennedy GL
    Toxicol Lett; 1987 Dec; 39(2-3):295-300. PubMed ID: 3686556
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.
    Yang Q; Abedi-Valugerdi M; Xie Y; Zhao XY; Möller G; Nelson BD; DePierre JW
    Int Immunopharmacol; 2002 Feb; 2(2-3):389-97. PubMed ID: 11811941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An in-vitro investigation of the effect of perfluorooctane sulphonate on cell lines of embryonic origin.
    Karakas-Celik S; Aras N
    Mol Biol Rep; 2014 Jun; 41(6):3755-9. PubMed ID: 24535269
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tiger nut/coconut dietary intervention as antidotal nutritional remediation strategy against neurobehavioural deficits following organophosphate-induced gut-brain axis dysregulation in mice.
    Enye LA; Edem EE; Onyeogaziri LI; Yusuf A; Ikpade BO; Ikuelogbon DA; Kunlere OE; Adedokun MA
    Toxicol Rep; 2024 Jun; 12():23-40. PubMed ID: 38193024
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS).
    Ehrlich V; Bil W; Vandebriel R; Granum B; Luijten M; Lindeman B; Grandjean P; Kaiser AM; Hauzenberger I; Hartmann C; Gundacker C; Uhl M
    Environ Health; 2023 Feb; 22(1):19. PubMed ID: 36814257
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure.
    Zhang L; Louie A; Rigutto G; Guo H; Zhao Y; Ahn S; Dahlberg S; Sholinbeck M; Smith MT
    Environ Res; 2023 Mar; 220():115188. PubMed ID: 36592815
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells.
    Janssen AWF; Louisse J; Rijkers D; Pinckaers NET; Hoekstra SA; Hoogenboom RLAP; Peijnenburg AACM; Beekmann K
    Arch Toxicol; 2022 Nov; 97(2):457-68. PubMed ID: 36326898
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice.
    Torres L; Redko A; Limper C; Imbiakha B; Chang S; August A
    Immunol Lett; 2021 May; 233():31-41. PubMed ID: 33722553
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk to human health related to the presence of perfluoroalkyl substances in food.
    ; Schrenk D; Bignami M; Bodin L; Chipman JK; Del Mazo J; Grasl-Kraupp B; Hogstrand C; Hoogenboom LR; Leblanc JC; Nebbia CS; Nielsen E; Ntzani E; Petersen A; Sand S; Vleminckx C; Wallace H; Barregård L; Ceccatelli S; Cravedi JP; Halldorsson TI; Haug LS; Johansson N; Knutsen HK; Rose M; Roudot AC; Van Loveren H; Vollmer G; Mackay K; Riolo F; Schwerdtle T
    EFSA J; 2020 Sep; 18(9):e06223. PubMed ID: 32994824
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food.
    ; Knutsen HK; Alexander J; Barregård L; Bignami M; Brüschweiler B; Ceccatelli S; Cottrill B; Dinovi M; Edler L; Grasl-Kraupp B; Hogstrand C; Hoogenboom LR; Nebbia CS; Oswald IP; Petersen A; Rose M; Roudot AC; Vleminckx C; Vollmer G; Wallace H; Bodin L; Cravedi JP; Halldorsson TI; Haug LS; Johansson N; van Loveren H; Gergelova P; Mackay K; Levorato S; van Manen M; Schwerdtle T
    EFSA J; 2018 Dec; 16(12):e05194. PubMed ID: 32625773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.